Corey Rosen
Aetna Prevails in Stock-Drop Lawsuit
In Radcliffe v. Aetna, Inc., No. 3:20-cv-01274, 2021 WL 4477408 (D. Conn. Sept. 30, 2021) a district court said that plaintiffs failed to state a claim concerning the continued holding of Aetna stock while the stock price was artificially inflated. Aetna is a subsidiary of CVS Healthcare, and CVS stock declined after changes in its accounting practices. The court ruled that neither Aetna nor CVS was a fiduciary because investment decisions were delegated to the Aetna Benefits Finance Committee. Because all alleged nonpublic information about the risks to CVS’s stock had already been disclosed by CVS in public filings with the SEC, the court ruled that the market had already incorporated this information into the pricing of the shares and plaintiffs had the information available to them.